Evidence map›Paper›PMID 30637663›Full record

SynthesisImmunologic research2019

The relationship between pemphigus and systemic lupus erythematosus: a cross-sectional study, systematic review, and meta-analysis.

Khalaf Kridin, Rimma Laufer-Britva, Mouhammad Kridin, Doron Comaneshter, Erez Batat, Arnon D Cohen

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Immunologic research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Vesiculobullous diseases in relation to lupus erythematosus.Clinical, cosmetic and investigational dermatology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Khalaf KridinDepartment of Dermatology, Rambam Health Care Campus, POB 9602, 31096, Haifa, Israel. dr_kridin@hotmail.com.ORCID 0000-0001-9971-9151
Rimma Laufer-BritvaDepartment of Dermatology, Rambam Health Care Campus, POB 9602, 31096, Haifa, Israel.
Mouhammad KridinSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Doron ComaneshterDepartment of Quality Measurements and Research, Chief Physician's Office, Clalit Health Services, Tel Aviv, Israel.
Erez BatatDepartment of Quality Measurements and Research, Chief Physician's Office, Clalit Health Services, Tel Aviv, Israel.
Arnon D CohenDepartment of Quality Measurements and Research, Chief Physician's Office, Clalit Health Services, Tel Aviv, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coexistence of pemphigus and systemic lupus erythematosus (SLE) had been reported anecdotally. Anti-desmoglein (Dsg)1 and anti-Dsg3 antibodies were detected concomitantly with antinuclear autoantibodies among blood donors. The aim of the current study was to study the association between pemphigus and SLE in Israeli patients and to synthesize existing data on this association in the current literature. The current study included two sections. Initially, a cross-sectional study was performed to compare pemphigus patients with age-, sex-, and ethnicity-matched control subjects regarding the prevalence of SLE using a real-life large-scale computerized database. Next, a systematic review and meta-analysis of similar observational studies in Medline, Embase, and Web of Science (1823-2017) was conducted. As for the cross-sectional study, a total of 1985 patients with pemphigus and 9874 controls were included in the study. The prevalence of SLE was slightly higher among patients with pemphigus as compared to controls (OR, 1.85; 95% CI, 0.89-3.82). In a sensitivity analysis that included patients who received pemphigus-related treatments, the association between pemphigus and SLE had been substantiated and was statistically significant (OR, 2.10; 95% CI, 1.00-4.48). In the meta-analysis section, three eligible studies, comprising 10,389 pemphigus patients met the eligibility criteria. The overall pooled multivariate OR was 2.50 (95% CI 1.54-4.07, I

Indexed as

AgedAged, 80 and overAntibodies, AntinuclearAutoantibodiesB-LymphocytesComorbidityCross-Sectional StudiesDesmoglein 1Desmoglein 3FemaleHumansIsraelLupus Erythematosus, SystemicMaleMiddle AgedPemphigusAntibodies, AntinuclearAutoantibodiesDesmoglein 1Desmoglein 3AssociationLupusMeta-analysisPemphigusSLESystematic reviewSystemic lupus erythematosus

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.